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BLOOD GASES AND RETINOPATHY OF PREMATURITY: THE EXTREMELY
LOW GESTATIONAL AGE NEWBORN STUDY. Alisse K. Hauspurg and Richard
A. Ehrenkranz. Department of Pediatrics, Yale Univeristy School of Medicine,
New Haven, CT.

This study tested the hypothesis that preterm infants who had a blood gas
derangement on at least 2 of the first 3 postnatal days are at increased risk for
more severe retinopathy of prematurity (ROP). 1,042 infants born before 28
weeks’ gestational age (GA) were included. An infant was considered at risk if
his/her blood gas measure was in the highest or lowest quartile for GA on at least
2 of the first 3 postnatal days. Multivariable models adjusting for confounders
indicate that exposure to a PCO2 in the highest quartile predicts ROP stage 3, 4
or 5: (OR = 1.6, 95% CI = 1.1–2.3); zone 1: 2.0, 1.1–3.6; prethreshold/threshold:
1.9, 1.2–3.0; plus disease: 1.8, 1.1–2.9. Estimates are similar for a low pH for
zone 1 (2.1, 1.2–3.8), prethreshold/threshold (1.8, 1.1–2.8), but did not quite
achieve statistical significance for ROP stage 3, 4, or 5 (1.4, 0.9–2.0) and plus
disease (1.5, 0.9–2.4). A PaO2 in the highest quartile for GA on at least 2 of the
first 3 postnatal days was associated with a doubling of the risk of ROP in zone 1
(2.5, 1.4–4.4) and of prethreshold/threshold disease (2.1, 1.4–3.3), a 70% risk
increase for plus disease (1.7, 1.04–2.8), while a 40% risk increase for ROP
stage 3 or higher did not achieve statistical significance (1.4, 0.96–2.0). Infants
who experienced high PCO2, low pH and high PaO2 during the first three prenatal
days appear to be at increased risk of more severe ROP.
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Introduction
Extremely Low Gestational Age Newborns (ELGANs), or infants born at
less than 28 weeks gestational age (GA), are at a high risk of developing
retinopathy of prematurity (ROP), a developmental vascular disorder that is one
of the most common causes of pediatric blindness in the United States (1,2). The
smallest, most preterm infants, who have an increased survival rate with recent
advances in neonatal care, also experience the most severe forms of ROP (3).
The history of ROP dates back to its initial discovery by Dr. Theodore L.
Terry in 1942. Terry described an infant with grey, blood vessel-covered
membranes behind its pupil, and hypothesized that "some new factor has arisen
in extreme prematurity to produce such a condition." As the number of described
cases increased, the condition became known as retrolental fibroplasia (RLF).
One of the factors Terry originally considered in his early case reports was the
excess exposure of premature infants to light, leading to early activation of
pupillary and ciliary body musculature (4). Other factors he suggested could be
contributing to the development of RLF included genetic factors, premature
closure of the ductus arteriosus and foramen ovale, hyperoxia, hypoxia,
hypothermia or endocrine factors (5).
It was noted to be increasingly common in premature infants, and it was
recognized that infants were not born with RLF but rather developed it after birth
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(6). Researchers continued to suggest various theories to explain and attempt to
prevent this epidemic of blindness, including maternal factors, multiple
gestations, infection, poor nutrition, iron deficiency, and other vitamin deficiencies
(7).
As multiple risk factors leading to RLF were examined and dismissed, the
prominent role of oxygen in its development was discovered with the first
multicenter randomized controlled trial conducted by Kinsey and Hemphill (8).
This study challenged the standard practice of administering 50% oxygen to
premature infants in the first 4 weeks of life to prevent apnea of prematurity.
Instead, infants randomized to the experimental group received room air oxygen
unless they became cyanotic, at which point oxygen administration was
increased, however, never to above 50%. Infants who received lower levels of
oxygen developed RLF at much lower rates and with much less severity. Many
did not develop RLF at all. The results of this trial were the first evidence of the
role that oxygen played in the development of RLF. Following this, clinicians and
researchers alike attributed the development of RLF to excess oxygen exposure
alone, and thus, oxygen use was restricted in nurseries (8).
During this time, many researchers observed that in some cases RLF
occurred with similar frequency in infants who did not receive oxygen. These
cases were initially thought to be exceptions to the rule, and many were
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dismissed as anomalies. In fact, many authors during this time called attention to
the weakness of the oxygen hypothesis, but their criticism was largely ignored
(7). Throughout the 1950s and 1960s, RLF nearly disappeared. Medical students
were hardly taught about it, as it was thought to be a condition of past mistakes
in neonatology. However, it is worth noting that despite tight control on oxygen
administration to preterm infants, there were still a number of cases of RLF
described.
During this time the “40% rule” arose in many clinical centers, which
emphasized that 40% oxygen was safe for the eyes of premature infants, but any
higher level of oxygen was dangerous. Despite the seeming protection of infants’
eyes from RLF with the curtailing of oxygen, neonatal mortality actually rose, as
did spastic diplegia (9). Later investigations estimated that for every case of
blindness prevented with control of oxygen therapy, approximately 16 infants
died secondary to inadequate oxygenation (10). Following these developments,
researchers began to advocate more “judicious” use of oxygen in the mid-1960s.
However, it warrants mention that during this time, there were no
intravenous fluids, and no ventilators, thus there were very few interventions
performed by neonatologists during these years. As these modalities of care
were implemented in neonatal intensive care units in the mid-1970s, survival of
preterm infants significantly improved. With improved survival at increasingly low
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gestational ages, however, came a reemergence of RLF at extremely high rates,
which could no longer be solely attributed to high oxygen exposure (7).
Animal studies conducted during this period seemed to suggest that it was
not only oxygen, but also the degree of prematurity of the eye that was among
the critical risk factors for development of the disease. Secondary to these
findings, RLF was renamed retinopathy of prematurity (ROP). It was
subsequently found that the greater the degree of immaturity of the eye (or
prematurity of the infant) the greater the risk of ROP (7). Techniques began to
develop to provide optimum oxygen amounts to maximize survival without
damage to the brain, while attempting to minimize the risks of development of
ROP. However, during this period, a second epidemic of ROP occurred, in spite
of attempts to carefully control oxygen therapy. Researchers estimated that
during this second epidemic, the number of infants blinded by ROP each year
was comparable to the number blinded during the first epidemic, which spanned
ten years between 1943 and 1953 (7).
In spite of the seemingly widespread recognition of the existence of ROP
and the extensive research into predisposing factors for its development, there
was no universal method of classifying the progression of ROP or its severity
until the early 1980s. The classification system, International Classification of
ROP (ICROP) was developed by neonatologists and ophthalmologists together
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and first described in the literature in 1984. The ICROP system utilizes several
different components to classify ROP, including position (zone), severity (stage),
extent (clock hours) and presence or absence of plus disease (12). For a visual
depiction of the ICROP classification system, see figure 1.
In terms of zones of the retina, ICROP describes three zones; with vessels
growing from the optic disc initially crossing zone I, then zone II, and finally
crossing zone III to reach the ora serrata. The blood vessels grow from the optic
disc beginning at approximately 16 weeks GA, as such, the more premature an
infant is, the less progress the vessels will have made towards the ora serrata.
Thus, ROP seen in zone I initially has a much worse prognosis than that of ROP
seen in zone III, which generally has a more benign, milder course (12).
Similarly, classification of stages of ROP is based on the overproduction of
vessels at the transition between the vascularized and avascular retina. The
abnormal vascular response at the junction of the vascularized and avascular
retina is classified as stage 1 through stage 5, with stage 5 representing the most
severe disease. Stage 1 is characterized by a thin demarcation line separating
the vascularized retina anteriorly from the avascular retina posteriorly. There is
abnormal branching of vessels leading up to the demarcation line. In stage 1
ROP, the line is relatively flat, white and is within the same plane as the retina.
Stage 2 ROP is characterized by the progression of the demarcation line in stage
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1 into a ridge. The ridge has height, width and extends above the retinal plane, in
contrast to the demarcation line, which, as previously mentioned is relatively flat.
In stage 3 disease immature vessels break through the retina, and this
neovascularization extends from the ridge into the vitreous. For a visual
depiction of the progression of the demarcation line from stage 1 through stage 3
ROP, see figure 2. Stage 4 disease is characterized by partial retinal
detachment. Finally, stage 5 ROP, the most severe stage, represents complete
detachment of the retina (13). For more detailed descriptions of specific retinal
findings associated with each ROP stage, see table 1.
The clock hours, or extent classification describes the number of clock
hours of the zone that contains the stage of ROP identified, and further serves to
describe the degree of ROP present (12). For a visual depiction of the clock
hours classification, see figure 1.
Finally, “plus disease” is encompassed by a “waviness” of the retinal
vessels, which represents increased venous dilatation and arteriolar tortuosity of
the posterior retinal vessels (see figure 2). This finding is concerning, because it
is thought that the most severe type of ROP that leads to retinal detachment
always progresses through plus disease prior to retinal detachment (12). It can
later increase in severity to include iris vascular engorgement, a rigid pupil and a
vitreous haze (13).
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Subsequently, in clinical trials testing the efficacy of cryotherapy for ROP,
further definitions of ROP were developed. “Threshold” ROP is defined as ROP
in either zone I or zone II, at least 5 continuous or 8 composite clock hours of
stage 3 and plus disease. This classification was found to be clinically useful in
that untreated threshold ROP progresses to retinal detachment about half the
time. “Prethreshold” ROP represents less severe disease and is used more as a
marker for identifying infants at risk for progression to threshold disease and
requiring more frequent eye examinations (12).
There are two other classifications of the disease that were described as
recently as 2005 (13), and reflect the changing nature of our understanding of the
progression of ROP. Pre-plus disease is defined as vascular abnormalities of the
posterior pole that demonstrate more arterial tortuosity than normal but do not
meet the diagnostic criteria for plus disease. Over time, the abnormalities of preplus disease may progress to plus disease as the vessels become more tortuous
(13).
A less common, but rapidly progressive, severe form of ROP was also first
defined in the literature in 2005 (13), and is termed aggressive posterior ROP
(AP-ROP). It had been previously referred to as “type II ROP” or “Rush disease,”
but it was not included in the initial publication of ICROP. This form of ROP is
characterized by its posterior location, the prominence of plus disease and a
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poorly defined nature of the retinopathy. Further, the diagnosis can be made on a
single eye examination, and does not require evaluation over time. AP-ROP is
most commonly observed in zone I, and may not progress through the classic
stages 1 to 3. Finally, as AP-ROP can appear as only a flat area of
neovascularization at the featureless junction between vascularized and
nonvascularized retina, it can easily be overlooked by a lesser experienced
clinician or examiner (13).
The natural history of ROP is very clearly linked to GA, as infants born at
less than 27 weeks almost always develop some degree of ROP. ROP is rarely
seen prior to 4 weeks after delivery, and it occurs even later in infants born at
lower gestational ages. Thus, ROP is most commonly seen after 31 weeks
postmenstrual age (i.e. gestational age at birth plus chronological age). Once it
begins, it typically involves only a few clock hours at stage 1 or 2, which
eventually progress over time, however, the zone involved typically doesn’t
change (12). Treatment for ROP involves cryoablation of the immature,
nonvascularized retina at the periphery or laser photocoagulation to ablate the
peripheral retina. Both interventions have been shown to be equally effective at
reducing unfavorable visual outcomes (14).
There is also evidence of the proven benefits of timely treatment of ROP
in reducing the risk of visual loss, which has raised questions regarding optimal
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screening guidelines (14). The American Academy of Pediatrics (AAP) recently
published a policy statement outlining ROP screening guidelines for preterm
infants. Recommendations address conditions for screening, timing of screening
and treatment, follow-up and conditions for discontinuing screening (14).
In terms of conditions for screening, infants born at less than 32 weeks or
a birth weight of less than 1500 grams, or infants with an unstable clinical course
should have a screening exam. One examination is appropriate only if it
undoubtedly shows full retinal vascularization in both eyes. An ophthalmologist
with sufficient knowledge and experience with ROP to enable accurate
identification should perform exams with pupillary dilation. Initiation of screening
is based on postmenstrual age (PMA), with most screening recommended
between 31 and 36 weeks PMA (14).
Follow-up screening exams are based on the severity of ROP noted on
initial exam. Infants with stage 1 or 2 ROP in zone I or stage 3 ROP in zone II
should have much closer follow-up, with a repeat exam occurring within 1 week
or less. Infants with immature vascularization in zone I but no ROP, stage 2 ROP
in zone II or regressing ROP in zone I should be reexamined within 1-2 weeks.
Two-week follow-up can occur for infants with stage I or regressing ROP in zone
II. Finally reexamination in 2-3 weeks is appropriate for infants with immature
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vascularization with no ROP in zone II, stage 1 or 2 or regressing ROP in zone III
(14).
Infants that require treatment with peripheral ablation rather than follow-up
screening include those with any plus disease, zone 1 ROP at any stage with
plus disease or at stage 3 with no plus disease or zone II, stage 2 or 3 with plus
disease. The AAP recommends treatment within 72 hours of identifying treatable
disease to minimize progression to retinal detachment. Infants should continue to
be screened at the aforementioned intervals until they have attained findings that
are appropriate for conclusion of screening. Those conditions include attainment
of zone III retinal vascularization without previous zone I or II ROP, full retinal
vascularization, PMA of 45 weeks and no prethreshold disease, or regression of
ROP (14).
The basis for the current screening and treatment guidelines comes from
a number of clinical trials conducted over the previous two decades. Stemming
from Terry’s initial hypothesis regarding the exposure of premature infants to
excess light, the LIGHT-ROP trial (15) tested the long-held belief that hospitalnursery lighting contributes to the development of ROP. This study found that a
reduction in ambient-light exposure did not in fact change the incidence of ROP
(15). The Multicenter Trial of Cryotherapy for Retinopathy of Prematurity or the
CRYO-ROP trial (16) began in 1986. This trial was conducted to evaluate the
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safety and efficacy of cryotherapy for ROP and also to determine the long-term
outcomes of eyes with threshold ROP that were either treated with cryotherapy
or left untreated. The authors found that cryotherapy reduces the risk of
unfavorable retinal and functional outcomes from threshold ROP. Visual
outcomes at ten years of age supported the long-term safety and efficacy of
cyrotherapy for threshold ROP (16).
The authors of The Early Treatment for Retinopathy of Prematurity or the
ETROP study (17) took CRYO-ROP a step further and sought to determine
whether there was any benefit to early versus conventionally timed ablation of
the peripheral retina. In this study, infants with bilateral high-risk prethreshold
ROP had one eye randomized to early retinal ablation while the other eye was
managed conservatively. This study found a significant reduction in unfavorable
outcomes in high-risk prethreshold eyes that were treated earlier (17), and these
results form the basis for current practice recommendations.
There are also a number of studies evaluating optimal oxygenation for
prevention of severe ROP. The Supplemental Therapeutic Oxygen for
Prethreshold Retinopathy of Prematurity, or STOP-ROP trial (18) evaluated the
safety of supplemental oxygen for infants with prethreshold ROP in reduction of
progression to threshold ROP and need for eventual ablation. The study found
that supplemental oxygen did not cause additional progression of prethreshold
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ROP, but also did not significantly decrease the number of infants requiring
ablation. The authors concluded that clinicians do not need to be concerned that
supplemental oxygen will exacerbate prethreshold ROP (18).
The most recent trial evaluating optimal oxygenation in prevention of ROP
is the SUPPORT trial (19), published in 2010. This trial randomized infants to
target oxygen saturations with one group attaining values ranging from 85 to 89%
and the other group to target saturations from 91 to 95% and studied whether
there was a difference in severe ROP between the two groups. The authors
found that the infants in the lower target range of oxygenation (85 to 89%) group
did have a decrease in severe ROP among survivors; however, there was an
increase in mortality among these infants (19). This increase in mortality is
concerning given the present goals of lower target oxygen saturation to prevent
ROP. These results call to mind the mistakes of neonatologists in the past, who
were so restrictive with their use of oxygen that each case of blindness they
prevented came at a cost of 16 infants’ lives (10).
The pathophysiology of ROP has been extensively researched since the
earliest studies linking its development to high oxygen levels. The most current
understanding of the factors leading to the development of ROP come from both
animal models and human studies, and are constantly being expanded upon.
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The pathogenesis of ROP is biphasic, with an initial phase of retinal blood vessel
degeneration followed by a second phase of neovascularization (20).
The first phase begins when retinal vascular growth ceases after
premature birth. It is during this time when vessels are particularly susceptible to
injury and can be obliterated by stressors such as oxygen supply and imbalance
of growth factors. Notably, during this time, decreased vascular endothelial
growth factor (VEGF) levels lead to suppression of vasoproliferation. This
downregulation of VEGF is a direct result of the higher oxygen levels infants are
exposed to after birth compared to the relative hypoxia in utero. VEGF
expression is triggered by hypoxia, and its downregulation results in
vasoobliteration of the retinal capillaries. This event is one of the first initiating
events in the development of ROP (21).
Subsequently, the relatively vascular-deplete retina becomes increasingly
hypoxic – mainly secondary to its lack of an adequate blood supply as well as
increased metabolic demands during its development. This hypoxia triggers the
second, or vasoproliferative phase of ROP. During this phase there is an
overproduction of hormones and growth factors in order to increase perfusion to
the hypoxic retina. Specifically, there is an increase in production of VEGF, and
other growth hormones, such as insulin-like growth factor 1 (IGF-1). These
factors lead to the formation of new vessels in a non-organized, excessive
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manner, and can lead to invasion of the vitreous, causing traction on the retina
and also bleeding (21). This abnormal growth of vessels can produce a fibrous
scar, which can retract and separate the retina from the retinal pigment
epithelium, resulting in retinal distortion or detachment (22).
Infants developing ROP are at risk not only for the retinal changes above
but also for a multitude of other ocular abnormalities, including myopia,
astigmatism, anisometropia and strabismus. Further, increased severity of ROP
is associated with increased prevalence and amount of myopia (23-25).
Low gestational age and low birth weight are the strongest risk factors
predicting ROP (26, 27). Others include low IGF-1 levels (28), varying VEGF
levels (29), systemic infection (30), inflammation (31), and genetic predisposition
(32, 33). Intraventricular hemorrhage appears to be associated with ROP,
probably because the same risk factors predispose very premature infants to
both conditions (1, 34).
Respiratory distress syndrome, and chronic in utero hypoxia also appear
to be associated with an increased risk of ROP, presumably through the effects
of respiratory dysfunction on arterial blood gases (35, 36). Despite this, the role
of blood gases and development of ROP is still unclear. Historically, as
discussed earlier, high arterial oxygen levels were implicated in the development
of ROP (37). However, more recently, widely fluctuating arterial oxygen tensions
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and timing of high or low blood oxygen concentrations were better predictors of
development and severity of ROP (38, 39).

Hypothesis
We hypothesized that ELGANs who have a blood gas extreme
(abnormality) on at least two of the first three postnatal days are at a higher risk
for more severe forms of ROP than infants who did not.

Methods
The ELGAN study was designed to identify characteristics and exposures
that increase the risk of structural and functional neurologic disorders in ELGANs
(40-46). During the years 2002-2004, women delivering before 28 weeks
gestation at one of 14 participating institutions in 11 cities in 5 states were asked
to enroll in the study. The enrollment and consent processes were approved by
the individual institutional review boards.
Mothers were approached for consent either upon antenatal admission or
shortly after delivery, depending on clinical circumstance and institutional
preference. 1249 mothers of 1506 infants consented. A total of 464 of these
infants died, were discharged before 36 weeks post-menstrual age, did not have
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blood gas assessments on at least 2 of the first 3 postnatal days or did not have
a retinal examination. The remaining 1042 infants comprise our sample for this
report (Table 2).

Demographic and pregnancy variables
After delivery, a trained research nurse interviewed each mother in her
native language using a structured data collection and following procedures
contained in a manual. The mother’s report of her own characteristics and
exposures, as well as the sequence of events leading to preterm delivery were
taken as truth, even when her medical record provided discrepant information.
Shortly after discharge, the research nurse reviewed the maternal chart
using a second structured data collection form. The medical record was relied on
for events following admission. The clinical circumstances that led to each
maternal admission and ultimately to each preterm delivery were operationally
defined using both data from the maternal interview and data abstracted from the
medical record (46).

Newborn variables
The GA estimates were based on a hierarchy of the quality of available
information. Most desirable were estimates based on the dates of embryo
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retrieval or intrauterine insemination or fetal ultrasound before the 14th week
(62%). When these were not available, reliance was placed sequentially on a
fetal ultrasound at 14 or more weeks (29%), last menstrual period (LMP) without
fetal ultrasound (7%), and GA recorded in the log of the neonatal intensive care
unit (1%). The birth weight Z-score is the number of standard deviations the
infant’s birth weight is above or below the median weight of infants at the same
gestational age in a standard data set (47).

Placentas
Placental histology and bacterial presence was documented in an effort to
characterize the relationship between placental characteristics, ROP severity and
blood gas derangements. Delivered placentas were placed in a sterile exam
basin and transported to a sampling room. Eighty-two percent of the samples
were obtained within 1 hour of delivery. The microbiologic procedures are
described in detail elsewhere (48, 49).

Blood gases
We classified ELGANs by their extreme blood gas measurements on
postnatal days 1, 2, and 3. On each of these days, we collected information
about the lowest, modal, and highest PaO2, PCO2, and pH. In our sample, the
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blood gas measurement that defined the extreme quartile varied by gestational
age and by postnatal day (Table 3). We therefore classified infants by whether or
not their extreme value each day was in the extreme quartile for their gestational
age (23-24, 25-26, and 27 weeks). Further, in order for an infant to be classified
as having a blood gas in an extreme quartile, the blood gas value had to be less
than (in the case of lowest quartiles) or greater than (in the case of highest
quartiles) the defined value for each quartile. Because an extreme measure on
one day could reflect a fleeting event, we required that an infant be in the
extreme quartile on at least two of the three days to be considered “exposed” to
such extremes.
Our not having blood gas measurements on all three of the first three
postnatal days might be an example of informative missingness. In essence,
children who did not have a blood gas on postnatal day 3 were more likely to be
physiologically stable than infants who had a set of blood gas measurements that
day. These children who did not have day 3 measurements are also much less
likely than others to have postnatal day 2 measurements that are in any extreme
quartile. Assigning these non-extreme measurements to postnatal day 3 seems
eminently reasonable, and allows us to include these children in this sample, and
thereby avoids our inflating odds ratios inappropriately.
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Eye examinations
Participating ophthalmologists helped prepare a manual and data
collection form, and then participated in efforts to minimize observer variability.
Definitions of terms were those accepted by the International Committee for
Classification of ROP (12). In keeping with guidelines (50), the first
ophthalmologic examination was within the 31st to 33rd post-menstrual week.
Follow-up exams were as clinically indicated until normal vascularization began
in zone III.

Data Analysis
The generalized form of the null hypotheses which we evaluated is that
children who have a blood gas extreme (abnormality) on two of the first three
postnatal days are not at higher risk of any form of ROP than children who did
not have that blood gas extreme on two of the first three postnatal days. We
evaluated five blood gas extremes (lowest quartile of PaO2, highest quartile of
PaO2, lowest quartile of PCO2, highest quartile of PCO2, lowest quartile of pH) in
models that included the three of the other four blood gas extremes as well as
other potential confounders. All conditional logistic multivariable models included
a hospital cluster term (to account for the probability that infants born at a
particular hospital are more like each other than like infants born at other
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hospitals) (51). The contributions of relevant variables are presented as risk
ratios with 95% confidence intervals.
In this sample, children who had a PCO2 in the highest quartile tended to
have a pH in the lowest quartile more commonly than expected if their cooccurrence was independent of the other. As expected, models with both of
these variables provided evidence that these two variables shared discriminating
information. Consequently, we present two multivariable models for each ROP
classification, Model 1 invariably includes a variable for low pH, but not a variable
for high PCO2. Model 2, on the other hand, has a variable for high PCO2, but not
a variable for low pH.
We summarize some of our data with box and whiskers displays of the
central tendency and dispersion of blood gases in ROP groups (Figure 3). The
central tendency is indicated by the line close to the middle of the box, which is
the median, and by the top and bottom of each box, which indicate the 25th and
75th centiles. The dispersion of blood gases is indicated by the length of the
vertical lines that emanate from the box, as well as by the block dots, which
identify outliers.
Others involved in the study conducted the initial data collection for the
larger database. For this project, I played a significant role in the study design
along with Drs. Olaf Dammann and Alan Leviton. I analyzed the raw data from
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the ELGAN database along with Elizabeth Allred. I complied the tables and
figures, identified confounders and developed all the models described below
along with Ms. Allred.

Results
Blood gas extremes were associated with an increased ROP risk on each
postnatal day (Figure 3). We observed an upward trend for each postnatal day
for oxygen and carbon dioxide extremes, with higher levels of each blood gas
associated with more severe forms of ROP. Infants with more severe forms of
ROP show a trend towards lower pH levels on each postnatal day.

Maternal characteristics, illness and medication use (Table 4)
Infants of mothers who used aspirin had a considerably increased risk of
developing more severe stages of ROP—nearly half of those infants developed
stage 3+ ROP. Further, these infants also were more likely to experience an
exposure to lower arterial blood oxygen and less likely to be exposed to higher
arterial blood oxygen. Mothers with a white blood cell (WBC) count higher than
20,000 within the interval before delivery to 48 hours post delivery were more
likely to have infants with a more severe stage of ROP, with 35% of those infants
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developing severe ROP. However, their infants were not at an increased risk of
experiencing blood gas extremes. While maternal fever was not associated with
having an infant at an increased risk of any stage of ROP, it was associated with
increased exposure to CO2 levels in the highest quartile.

Delivery characteristics (Table 4)
Mothers with preeclampsia or a fetal indication for preterm delivery were
more likely to have infants with more severe stages of ROP. In addition, infants
of preeclamptic mothers were at a considerably greater risk for exposure to
higher PCO2 levels. Infants delivered due to fetal indication were more likely to
experience exposure to not just higher PCO2 levels, but also lower arterial
oxygen levels and lower pH levels.

Placenta bacteriology and histology (Table 5)
The presence of any mycoplasma in the placenta or thrombosis of fetal
stem vessels was not associated with an increased risk of an infant’s
development of ROP. However, infants with mycoplasma in their placentas were
more likely to experience an exposure to lower CO2 and less likely to be exposed
to higher CO2 levels. Infants with placentas with thrombosis of fetal stem vessels
were more likely to be exposed to lower pH levels. Decidual hemorrhage or fibrin
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deposition was associated with an increased risk for development of more severe
ROP, with 32% of those infants developing stage 2 ROP, and 35% developing
severe ROP. Decidual hemorrhage or fibrin deposition, however, were not
associated with an increased risk of exposure to blood gas extremes.

Infant characteristics (Table 6)
Within each gestational age stratum, the blood gas values that defined the
highest and lowest quartiles were consistently more extreme on the first three
postnatal days for infants of lower gestational age (Table 3). Lower gestational
age and lower birth weight Z-score was highly correlated with increased
development of more severe forms of ROP. Fifty-four percent of infants born at
23-24 weeks GA developed stage 3+ ROP compared to 31% of infants born
between 25-26 weeks and just 11% of infants born at 27 weeks GA. Infants of
lower birth weight and birth weight Z-score also developed more severe forms of
ROP at a considerably increased rate. Nearly half of infants (49%) with a birth
weight Z-score less than -2 developed stage 3+ ROP. These infants with the
lowest birth weight Z-score were also much more likely to experience exposure
to a lower pH or higher CO2 levels. The same relationships hold true for infants
with head circumference Z-scores, with infants with the lowest Z-scores more
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likely to develop more severe forms of ROP and more likely to experience
exposures to lower pH and higher PCO2.

ROP severity classifications and blood gases (Table 7)
Infants with stage 3 or higher ROP were more likely than their peers to be
exposed to a high PaO2. Further, infants with plus disease were more likely than
their peers to be exposed to a high PCO2 or low pH. Stratifying newborns by the
presence/absence of zone 1 or prethreshold/ threshold disease resulted in even
more prominent differences in hyperoxemia frequency, as well as prominent
differences in frequencies of hypercapnia and acidemia. This increased
difference is probably due to the fact that ‘stage 3 or higher’ includes ROP in all
zones, thereby diluting the effect.

Multi-variable analyses (Table 8)
After adjustment for confounders, our multivariable models indicated
several significant relationships between blood gas extremes and ROP, which
were more prominent when ROP was dichotomized by zone or prethreshold/threshold than by stage. First, higher arterial O2 levels were
significantly associated with zone 1, pre-threshold and threshold ROP, and the
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presence of plus disease, while the association with stage 3 or higher disease
did not reach statistical significance (both models). Second, high PCO2 levels
were invariably significantly associated with increased risk of ROP stage 3 or
higher, zone 1, pre- threshold and threshold ROP and the presence of plus
disease (model 1). Third, very similar effects were present with exposure to low
pH (model 2). Infants who experienced high PCO2, low pH and high PaO2
appear to be at an increased risk for development of more severe ROP, as will
be further described below.
Infants who experienced the highest PaO2 levels were 40% more likely to
develop stage 3 or higher ROP in both models; model 1 (1.4, 0.95-2.0) and
model 2 (1.4, 0.96-2.0). These infants were also significantly more likely to
develop zone I disease; model 1 (2.5, 1.5-4.5) and model 2 (2.5, 1.4-4.4). They
were also more than two times more likely to develop pre-threshold or threshold
disease; model 1 (2.1, 1.3-3.3) and model 2 (2.1, 1.4-3.3). Finally, infants with a
PaO2 in the highest quartile were 70% more likely to develop plus disease;
model 1 (1.7, 1.02-2.7) and model 2 (1.7, 1.04-2.8).
Likewise, infants who experienced the highest PCO2 levels were also
much more likely than their peers to develop severe ROP in model 1. These
infants were 60% more likely to develop stage 3 or higher (1.6, 1.1-2.3). They
were significantly more likely to develop zone I disease (2.0, 1.1-3.6), and pre-
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threshold or threshold disease (1.9, 1.2-3.0). Finally, infants exposed to the
highest quartile of PCO2 levels were 80% more likely to subsequently develop
plus disease (1.8, 1.1-2.9).
Similarly, infants exposed to the lowest pH levels were also much more
likely to develop severe ROP in model 2. These infants were more likely to
develop stage 3 or higher ROP (1.4, 0.9-2.0), although non-significantly. They
were significantly more likely to develop zone I disease (2.1, 1.2-3.8). Infants with
the lowest pH levels were 80% more likely to develop pre-threshold or threshold
disease (1.8, 1.1-2.8). Finally, these infants were also more likely to develop plus
disease (1.5, 0.9-2.4), although again, non-significantly.

Discussion
This is the first large-scale epidemiologic study showing an association
between blood gas disturbances and risk of ROP development in ELGANs. Our
main finding is that exposure to high blood oxygen, high carbon dioxide
concentrations or low pH is significantly associated with an increased risk of
severe forms of ROP. These relationships remain statistically significant even
after adjustment for confounders.
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Hypercarbia and both metabolic and respiratory acidosis increase retinal
neovascularization in animal models (52, 53). These models propose that
hypercarbia affects the retinal vasculature through vessel dilation, which can lead
to increased oxygenation and increased retinal blood flow (54), which in turn may
contribute to abnormal retinal vascularization (37).
However, prior clinical studies assessing the role of blood gases in ROP
development have yielded inconsistent results (39, 55). In a study of 91
mechanically-ventilated infants of mean gestational age 29 weeks, a
measurement of hypercarbia or hypocarbia on the first three postnatal days was
not associated with an increased risk of ROP development (55). The authors
suggested that cumulative exposure integrated over time might be a better way
to capture potentially adverse events than single measurements. Similar results
were found in another underpowered study, of 25 infants less than 30 weeks
gestational age, in which mean transcutaneous PCO2 was correlated to ROP
development (56). Both studies cited the need for further investigation with
larger cohorts. Additionally, effects of pH on development of ROP have not been
fully investigated in clinical studies, despite an abundance of evidence in animal
models suggesting acidosis as a risk factor for ROP (52, 53).
In contrast to the studies mentioned above, our study defined an exposure
as a blood gas measure in the highest or lowest quartile for gestational age on
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two of the first three postnatal days, rather than defining an upper limit, or using
mean values. In this way, we are able to better identify infants with an exposure
to a blood gas extreme during the first three postnatal days.
The infants in our study experienced PCO2 extremes that exceed the
values defined as hypercarbia in previous studies (55). We found that exposure
to a PCO2 in the highest quartile was greatly associated with increased risk of
severe ROP.
Current clinical studies have not fully investigated or shown that
decreased pH is associated with increased ROP severity. Our model showed
that decreased pH is highly correlated with an increased risk of more severe
forms of ROP. We speculate that there could be a potential role for early sepsis
in the development of blood gas extremes and ROP severity.
Finally, our study adds to our knowledge about arterial oxygen levels and
ROP development. We found that exposure to higher arterial oxygen levels in the
first three postnatal days is strongly associated with increased ROP severity.
This is consistent with many current studies and the current clinical practice
advocating the benefits of lower blood oxygen saturation during the first few
weeks of life (57, 58). Several recent studies have found that lowering oxygen
alarm limit parameters leads to a decreased risk of more severe forms of ROP
(59), and better visual outcomes (60, 61).

33

While the studies discussed above have not found a significant link
between hypercarbia and ROP development, nor fully investigated the effects of
pH extremes on development of ROP, they have alluded to the need for a larger
sample size to generate more powerful data. Our study included 1042 ELGANs,
of whom, 800 (77%) developed any stage of ROP. Compared to previous studies
with sample sizes less than 100 infants, this is a huge increase in power. While
most prior studies did not fully address confounding, we created a multivariable
model adjusting for confounders. Consequently, we expect our results to provide
a better understanding of the relationship between blood gas extremes and
severity of ROP.
The weaknesses of our study are those of all observational studies. We
are unable to distinguish between causation and association as explanations for
what we found by looking at the data only. Further, we assume that an extreme
blood gas measure on two of the first three postnatal days constitutes an
“exposure.” This definition was necessary considering the limits of our data,
however, there is no published evidence for this definition. Finally, we are unable
to differentiate between respiratory and metabolic acidosis, a clinically relevant
distinction that is worth further investigation in future studies.
In light of the biologic plausibility of our findings, we suggest that bloodgas-associated ROP risk be considered in discussions of clinical practice. While
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oxygenation has dominated most of the recent ROP literature, the role of
hypercarbia and acidosis in severe ROP may warrant further clinical
consideration and study. This is especially important in light of recommendations
about the safety and efficacy of ‘permissive hypercarbia’ (62). Permissive
hypercarbia involves the adjustment of blood gas targets to allow higher than
normal PCO2 levels in premature infants to prevent lung injury. While permitting
higher PCO2 levels may indeed reduce ventilator-associated lung injuries, our
findings concerning the effects of hypercarbia on development of severe ROP
justify concerns raised in current discussions (63).

Conclusion
In summary, we found that independent exposure to high PCO2, high PaO2
or low pH during the first three days of life significantly increases risk of
development of more severe forms of ROP. Further research might help better
characterize such relationships and to develop more effective clinical parameters
for safe blood gas levels in ELGANs.
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Table 1. Description of retinal findings associated with each ROP stage
on ophthalmologic examination (12).
ROP Stage

Retinal Findings

No ROP

Vessels fade from vascularized retina into avascular
retina imperceptibly

Stage 1

Distinct line or flat demarcation (usually white or
yellowish) between transition from vascularized,
posterior retina to avascular, peripheral retina

Stage 2

Line (as described in stage 1 findings) becomes thicker
in height and width, more three-dimensional now known
as a ridge. Mass of growing immature vasculature, but
contained within retina

Stage 3

Vessels (as described in stage 2 findings) break
through the retina into the vitreous space, also known
as extraretinal neovascularization. This is source of
arterio-venous shunting and contractile elements that
can potentially lead to retinal detachment.

Stage 4

Retina begins to become detached, lifted or pulled off
choroidal bed

Stage 5

Complete retinal detachment
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Table 2. Sample description.
Yes

No

Enrolled

1506

Survived to day 7 and had a head ultrasound

1414

92

Had blood gas assessments on 2 days of days 1-3

1172

242

Had a retinal examination

1042

130
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Table 3. The values that define the highest and lowest quartiles of each
blood gas displayed on the left on each day in each gestational age group.
An infant is classified as having a blood gas in an extreme quartile, the blood
gas value had to be less than (in the case of lowest quartiles) or greater than
(in the case of highest quartiles) the defined value for each quartile.
Blood Gas

Postnatal

Gestational Age (weeks)

Day

23-24

25-26

27

Lowest Quartile

1

40

42

40

PaO2 (mmHg)

2

43

45

44

3

43

45

43

Highest Quartile

1

152

145

143

PaO2 (mmHg)

2

98

100

92

3

103

95

93

Lowest Quartile

1

27

29

29

PCO2 (mmHg)

2

33

35

35

3

33

33

35

Highest Quartile

1

65

67

63

PCO2 (mmHg)

2

60

64

60

3

58

57

56

Lowest Quartile

1

7.15

7.20

7.22

pH

2

7.14

7.17

7.22

3

7.16

7.19

7.22
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Table 4. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age
listed at the top of each column on at least two of the first three postnatal days in categories of maternal characteristics,
maternal illness and medication use and delivery characteristics. These are row percents.
Maternal/Delivery
Blood Gas Extreme
ROP Stage
Characteristic

Prepregnancy
BMI
Conception
assistance
Fever
Aspirin use
Highest
WBCØ

Initiator of
delivery

Ø

Lowest
P aO 2

Highest
P aO 2

Lowest
PCO2

Highest
PCO2

Lowest
pH

< 18.5
≥ 18.5, < 25
≥ 25, < 30
≥ 30
Yes
No
Yes

21
24
19
21
24
21
25

18
19
27
22
18
22
24

26
21
21
23
17
24
20

28
23
18
21
28
20
35

26
21
21
24
23
22
23

No

22

21

23

21

22

Yes

31

13

23

21

25

No

21

22

22

22

22

> 20K
≤ 20K
PTL
PPROM
Preeclampsia
Abruption
Cervical
insufficiency
Fetal
indication

24
21
19
26

23
20
20
21

18
23
21
26

21
22
18
21

26

29

22

12

20

23
40

N

None

1

2

3+

N

29
26
28
26
28
26
27

26
23
21
19
21
22
22

20
23
23
23
21
23
26

25
28
28
32
30
28
26

91
580
230
248
246
916
74

26

22

23

29

1088

21

18

18

44

62

27

22

23

28

1095

16
23
18
23

76
559
224
256
232
897
71
105
8
61
106
2
233
913
531
240

23
27
25
32

22
22
25
20

20
23
22
20

35
28
28
28

241
936
537
261

31

26

154

23

18

24

37

154

26

24

21

122

25

25

25

25

126

22

16

19

23

73

30

17

27

27

71

17

13

35

37

52

20

14

32

34

50

White blood cell count (WBC) within the interval from before delivery to 48 hours post delivery
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Table 5. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for ges
listed at the top of each column on at least two of the first three postnatal days in categories of placental h
organism presence. These are row percents.

21

Yes

29

16

23

27

32

62

No

22

22

21

21

21

1009

Yes

22

13

19

22

21

182

No

22

23

22

21

22

893

112

26

21

21

32

27

22

23

29

35

21

16

28

57

26

22

23

29

1040

16

17

32

35

179

23

21

28

925

947

Lowest
PCO2

28

N

111
968

21

27

23

15

Highest
PCO2

21

21

32

22

21

Lowest
pH

893

182

1009

62

947

112

N

28

16

26

35

27

26

None

23

17

22

21

22

21

1

21

32

23

16

23

21

2
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22

22

ROP Stag

21

Blood Gas Extreme

3+

30

21

23

21

19

22

2

19

21

16

22

13

23

1

19

22

None

Yes

23

Placenta
Characteristic

21

N

Highest
P aO 2

22

21

ROP Stage

Lowest
P aO 2

No

15

22

30

No

19

29

19

Yes

Yes

22

Lowest
pH

No

Highest
PCO2

22

Lowest
PCO2

Yes

Highest
P aO 2

22

Thrombosis
of fetal stem
vessels
Decidual
hemorrhage/
fibrin
deposition

Lowest
P aO 2

No

Any
Mycoplasma

Blood Gas Extreme

Any
Mycoplasma

Placenta
Characteristic

Thrombosis
of fetal stem
vessels
Decidual
hemorrhage/
fibrin
deposition

Table 5. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age
listed at the top of each column on at least two of the first three postnatal days in categories of placental histology and
organism presence. These are row percents.
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Table 6. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for g
listed at the top of each column on at least two of the first three postnatal days in categories of infant c
These are row percents.

Infant Characteristic

Blood Gas Extreme
Lowest
P aO 2

Highest
P aO 2

Lowest
PCO2

Highest
PCO2

Lowest
pH

N

ROP Stage

None

1

Lowest
P aO 2

14
22
27
13

2

27
24
18
30

Highest
P aO 2
Lowest
PCO2

28

20

26
17
17
23
13
19
23

15
22
31
22
32
26
21

Highest
PCO2

Blood Gas Extreme

23-24
22
21
22
23
24
321
5
25-26
22
20
22
21
20
536
23
27
23
23
22
23
23
315
44
≤ 750
24
22
22
26
27
523
10
Birth weight 75120
20
22
17
16
481
28
(grams)
1000
> 1000
20
22
21
21
19
168
53
< -2
23
22
27
27
38
78
12
!
BW Z score
< -1
29
25
25
32
28
173
13
≥ -1
21
20
21
20
19
921
29
< -2
25
24
21
28
29
105
15
Head
circumference < -1
23
20
28
23
25
253
22
!
Z score
≥ -1
20
22
21
20
19
773
29
!
Birth weight (BW) and head circumference Z-scores based on Yudkin et al. standard
Gestational
age (weeks)

Infant Characteristic

!

3+

N

54
31
11
47

248
556
395
443

24

519

7
49
39
26
40
33
27

237
65
155
979
91
258
807
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23-24
22
21
22
23
24
321
5
Gestational
25-26
22
20
22
21
20
536
23
age (weeks)
27
23
23
22
23
23
315
44
≤ 750
24
22
22
26
27
523
10
Birth weight 75120
20
22
17
16
481
28
(grams)
1000
> 1000
20
22
21
21
19
168
53
< -2
23
22
27
27
38
78
12
BW Z score! < -1
29
25
25
32
28
173
13
≥ -1
21
20
21
20
19
921
29
< -2
25
24
21
28
29
105
15
Head
circumference < -1
23
20
28
23
25
253
22
Z score!
≥ -1
20
22
21
20
19
773
29
Birth weight (BW) and head circumference Z-scores based on Yudkin et al. standard

Table 6. The distribution of ROP and infants who had a PaO2, PCO2, or pH in the extreme quartile for gestational age
listed at the top of each column on at least two of the first three postnatal days in categories of infant characteristics.
These are row percents.

N
None
1

RO

14
22
27
13

28

26
17
17
23
13
19
23
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Table 7. The percent of children classified by their ROP status (on the left) who
satisfied the blood gas criterion at the top of each column. These are row
percents.
Blood Gas Extreme
Lowest

Highest

Lowest

Highest

Lowest

quartile

quartile

quartile

quartile

quartile

Row

P aO 2

P aO 2

PCO2

PCO2

pH

N

Yes

20

27

24

26

25

331

No

23

19

21

20

20

711

Yes

20

37

19

30

35

89

No

22

20

22

21

20

953

Yes

25

31

21

33

32

174

or threshold

No

21

19

22

20

20

868

Plus disease

Yes

28

28

22

36

31

134

No

21

20

22

20

20

908

Overall

22

21

22

22

22

Column N

227

221

230

229

225

ROP severity

Stage 3, 4,
or 5
Zone 1
Prethreshold

1042

51
Table 8. Odds ratios1 (and 95% confidence intervals) of the association between
blood gas extremes (defined as a blood gas measure in the highest or lowest
quartile for gestational age) and the risk of ROP. The referent group for each set
of analyses consists of all children who did not have the ROP classification listed
at the top of each set of columns.
Stage 3, 4, or 5

Zone 1

Blood gas

Model 1

Model 2

Model 1

Model 2

Lowest PO2

0.9 (0.6, 1.4)

1.0 (0.7, 1.5)

0.6 (0.3, 1.1)

0.6 (0.3, 1.2)

Highest PO2

1.4 (0.95, 2.0)

1.4 (0.96, 2.0)

2.5 (1.5, 4.5)

2.5 (1.4, 4.4)

Lowest PCO2

0.8 (0.6, 1.2)

0.8 (0.6, 1.2)

0.7 (0.4, 1.5)

0.7 (0.4, 1.4)

Highest PCO2

1.6 (1.1, 2.3)

Lowest pH

2.0 (1.1, 3.6)
1.4 (0.9, 2.0)

Pre-threshold or threshold

2.1 (1.2, 3.8)

Plus disease

Blood gas

Model 1

Model 2

Model 1

Model 2

Lowest PO2

1.1 (0.7, 1.7)

1.1 (0.7, 1.8)

1.4 (0.9, 2.3)

1.5 (0.9, 2.4)

Highest PO2

2.1 (1.3, 3.3)

2.1 (1.4, 3.3)

1.7 (1.02, 2.7)

1.7 (1.04, 2.8)

Lowest PCO2

0.8 (0.5, 1.3)

0.8 (0.5, 1.3)

0.8 (0.5, 1.4)

0.8 (0.5, 1.4)

Highest PCO2

1.9 (1.2, 3.0)

Lowest pH
1

1.8 (1.1, 2.9)
1.8 (1.1, 2.8)

1.5 (0.9, 2.4)

All models are adjusted for maternal BMI > 30, maternal use of aspirin during
pregnancy, WBC > 20K within 48 hours of delivery, delivery for preeclampsia or
fetal indication, decidual hemorrhage/fibrin deposition in placenta, gestational
age (23-24, 25-26, 27 weeks) and birth weight Z-score < -1, definite early
sepsis, definite late sepsis and all of the other blood gas extremes in the model.
These models include a hospital cluster term to account for the possibility that
infants born at a particular hospital are more like each other than like infants born
at other hospitals.
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Right eye

Left eye
12

ZONE I

3

ZONE I

9

3
12

Ora serrata

ZONE II

Optic Nerve

ZONE I

Macula

Optic Nerve Macula

6

3
9

Ora serrata

6

Optic Nerve

ZONE II

6

Macula

ZONE III

ZONE III

ZONE II

9

Right eye

9

ZONE III

ZONE II

12

ZONE I

6

Optic Nerve Macula

Diagram depicting premature retina with demarcated zones. Zone I surrounds optic nerve
head. Also denoted around perimeter are clock hours (in red) to document extent of disease.
Retinal changes are recorded on a document such as the one above. Adapted from figure 1
in American Academy of Pediatrics Policy Statement: Screening Examination of Premature
Infants for Retinopathy of Prematurity (14).
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Diagram depicting premature retina with demarcated zones. Zone I surrounds optic nerve
head. Also denoted around perimeter are clock hours (in red) to document extent of disea
Retinal changes are recorded on a document such as the one above. Adapted from figure
in American Academy of Pediatrics Policy Statement: Screening Examination of Prematur
Infants for Retinopathy of Prematurity (14).

12

Left eye

ZONE III

3

Figure 1. Diagram of eyes showing zones and clock hours to describe location and extent of ROP

Figure 1. Diagram of eyes showing zones and clock hours to describe location and extent of ROP
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Figure 2. Photographs of ROP stages 1, 2 and 3, and plus disease, reproduced
with permission from figures 3,4, 6 and 10 in International Classification of
Retinopathy of Prematurity Revisited (13).
(a) ROP Stage 1

(b) ROP Stage 2

Figure 3. Fundus photograph to illustrate the demarcation line of stage 1. A, View of the demarcation
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Figure 3. Correlation between highest PaO2, highest PCO2 and lowest pH to
ROP stage
(a)

Highest PaO2 and ROP Stage
200

600

400

Highest PCO2

Highest PaO2

150

200

No S 1–2 S 3–5
Day 1

a

100

50

0

0
No S 1–2 S 3–5
Day 2

No S 1–2 S 3–5
Day 3

No S 1–2 S 3–
Day 1

b

7.6

Highest PCO2 and ROP Stage

7.4

200

150

Highest PCO2

Fig. 1. Box-and-whisker plots of highest PaO2 (a), highest PCO2
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each day. Because we cannot tell if extreme pH and PCO2 mea7.6 are paired, we did not calculate base excess. We did not
surements
require any blood gases to be taken as per protocol. All measurements7.4
were taken at the discretion of the attending physician.
Thus, there is no standardized frequency of blood gas measurements7.2
in this study.
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Box and Whisker plots comparing highest PO2 (a), highest PCO2 (b), and
lowest pH (c) to ROP stage, on each postnatal day. The median is indicated
by the line closest to the middle of the box, which indicates the 25th and 75th
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Data Analysis
The generalized form of the null hypothesis we evaluated is
that children who have a blood gas in an extreme quartile on 2 of
the first 3 postnatal days are not at higher risk of severe ROP than
children who did not have that blood gas extreme on 2 of the first
3 postnatal days. We evaluated five blood gas extremes (lowest
quartile of PaO2, highest quartile of PaO2, lowest quartile of PCO2,
highest quartile of PCO2, lowest quartile of pH) in models that
included the three of the other four blood gas extremes as well as
other confounders. Confounders were selected by their association with a blood gas extreme and stage 3 or higher ROP, biologic
plausibility or previous identification in the literature (table 2). All
conditional logistic multivariable models included a hospital cluster term (to account for the possibility that infants born at a particular hospital are more like each other than like infants born at
other hospitals) [23]. The contributions of relevant variables are
presented as risk ratios with 95% confidence intervals.
In this sample, children who had a PCO2 in the highest quartile tended to have a pH in the lowest quartile more commonly

Hauspurg et al.

